NCT06797583

Transcranial Photobiomodulation Treatment in Patients With Sickle Cell Disease

RecruitingNAINTERVENTIONAL

Trial Details

Start: 2026-11Est. Completion: 2027-12

Enrollment target: 60 participants

Contact

Sickle Cell Disease

The study will test a new medicine, etavopivat, for sickle cell disease and see if it is safe and help-ful for participa…

Raipur, IndiaEst. completion Aug 20, 2027

Sickle Cell Disease

The goal of this clinical trial is to evaluate whether a 4-week music therapy (MT) intervention can reduce chronic pain …

Atlanta, United StatesEst. completion Apr 1, 2028

MicrobiomeTrials does not provide medical advice. Always consult your doctor before joining a clinical trial.